Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v21-EN | Version v11-FR | |
---|---|---|
Language | English | French |
Date Updated | 2018-07-23 | 2018-05-08 |
Drug Identification Number | 01926551 | 01926551 |
Brand name | SECTRAL | SECTRAL |
Common or Proper name | SECTRAL 200MG | SECTRAL 200MG |
Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
Ingredients | ACEBUTOLOL | ACEBUTOLOL |
Strength(s) | 200MG | 200MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL | ORAL |
Packaging size | 100'S | 100'S |
ATC code | C07AB | C07AB |
ATC description | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2018-04-18 | 2018-04-18 |
Estimated end date | 2018-07-27 | 2018-06-04 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Increased demand possibly due to the generic being on back order. See also discontinuation posting Report ID 54767, for information on subsequent discontinuation once supplies are depleted | Increased demand as competitor is on shortage |
Health Canada comments |